|
Pfizer legal win might block some Celebrex lawsuits
2007-11-20
Pfizer Inc scored a victory Monday through a federal ruling that might wipe out some lawsuits alleging its painkiller Celebrex caused heart attacks and strokes, the Wall Street Journal reported in its online edition. Judge Charles Breyer of the U.S. District Court for the Northern District of California ruled that the plaintiffs in the litigation had not presented scientifically reliable evidence that Celebrex caused heart attacks or strokes when taken at a daily dosage of 200 milligrams, which is the most common dosage, the Journal said. There are more than 3,000 Celebrex plaintiffs -- according to the ruling -- but it is not clear how many the ruling will affect, the Journal said. Representatives of Pfizer could not immediately be reached for comment. "We are pleased with the decision of the federal court, which recognizes the lack of any credible evidence linking Celebrex, at its most common dosage form, with heart attacks or strokes," Pfizer General Counsel Allen Waxman said, according to the Journal. (Reporting by Justin Grant; Editing by Quentin Bryar)
|
